- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨129.6b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨406.82
7D
0.3%
1Y
161.2%
Highnoon Laboratories
Market Cap: PK₨61.5b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,160.15
7D
-4.9%
1Y
66.0%
Hoechst Pakistan
Market Cap: PK₨36.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,789.35
7D
-0.5%
1Y
87.1%
Abbott Laboratories (Pakistan)
Market Cap: PK₨112.1b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,144.94
7D
-2.5%
1Y
54.4%